$3.08
0.0050.16%
Last update: 11:19 AM
15 minutes delayed
Poseida Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Poseida Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $-0.32 | $-0.41 | 21.9 % |
Mar 2024 | 2024-05-14 | $-0.25 | $-0.42 | 40.5 % |
Dec 2023 | 2024-03-07 | $-0.27 | $-0.39 | 30.8 % |
Sep 2023 | 2023-11-09 | $-0.35 | $-0.29 | -20.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-05 | $25.97M | $15.43M | 68.3 % |
Mar 2024 | 2024-05-14 | $28.14M | $11.67M | 141.2 % |
Dec 2023 | 2024-03-07 | $25.00M | $6.65M | 275.9 % |
Sep 2023 | 2023-11-09 | $9.35M | $18.87M | -50.4 % |
Poseida Therapeutics (PSTX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.
The Actual EPS was $-0.32, which beat the estimate of $-0.41.
The Actual Revenue was $26M, which beat the estimate of $15.4M.
Browse earnings estimates, EPS, and revenue on all stocks.